It has recently been shown that an increased plasma level of the tryptophan catabolite kynurenine is an early indicator for the development of sepsis in major trauma patients. We examined the predictive value of kynurenine pathway activity for ongoing sepsis in patients being admitted to a surgical intensive care unit for different reasons. In addition, we asked whether an accumulation of kynurenines in patients' plasma depends on reduced renal clearance. We conducted a prospective observational study including 100 consecutive patients and monitored laboratory variables, physiological and adverse events, sepsis and outcome. Using tandem mass spectrometry, we quantified the five indoleamines tryptophan, serotonin (5-HT), kynurenine, quinolinic acid and kynurenic acid at baseline and twice a week during the intensive care unit stay. Among the patients enrolled, 50 did not develop sepsis in the intensive care unit (non-septic), 18 patients did not have sepsis at baseline but developed sepsis later on (preseptic) and 32 patients already fulfilled the criteria of severe sepsis and septic shock at baseline (septic). In general, non-septic critically ill patients showed activation of the kynurenine pathway, but septic shock coincided with an exacerbation of kynurenine pathway activity even in the absence of renal failure. Importantly, plasma concentrations of quinolinic acid (area under the curve 0.832 [95% confidence interval 0.710 to 0.954]) and the Quin/Trp ratio (area under the curve 0.835 [95% confidence interval; 0.719 to 0.952]) showed the best discrimination between non-septic and pre-septic patients at baseline. These findings open new avenues for further investigations on the pathophysiology of sepsis.
Of the dietary tryptophan (Trp) that is not used for protein biosynthesis, the majority is catabolised along the quinolinic branch of the kynurenine (Kyn) pathway to provide NAD + (Figure 1 ). The amino acid Trp is the sole source of substrate for de novo NAD + synthesis [1] [2] [3] . Two enzymes are able to catalyse the initial, rate-limiting step of Trp catabolism: indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxgenase (TDO). Previous in vitro and animal studies on macrophages or dendritic cells showed that bacterial products, such as the toll-like receptors ligands lipopolysaccaride or bacterial DNA 4, 5 , proinflammatory cytokines, such as tumor necrosis factor and interferon 1, 6 , or glucocorticoids 7 induce the upregulation of IDO 8 . In contrast, TDO, a house-keeping gene of hepatocytes, is not inducible by bacterial products or cytokines. Downstream of IDO or TDO, other kynurenine pathway enzymes 2, 9 promote the formation of various Trp catabolites, collectively known as kynurenines, e.g. kynurenine, quinolinic acid (Quin) or kynurenic acid (Kyna). In addition to Trp shortage, these Trp catabolites were identified as dampening proinflammatory immune responses 7, [10] [11] [12] [13] . T cells undergo cell cycle arrest when deprived of Trp, and become more sensitive to signals inducing apoptosis [14] [15] [16] . Additionally, several Kyns have pro-apoptotic functions themselves. They preferentially act on T helper 1 cells, thereby effectively reducing inflammation 15 . Recently, Kyna has been identified as blocking the LPS-inducible TNF production of human monocytes in vitro 17 . Last but not least, IDO + plasmacytoid dendritic cells create a suppressive microenvironment via activation of peripheral regulatory T cells 11, 18 . In addition, the depletion of Trp is known to reduce the pool of molecular precursors for serotonin synthesis, leading to depression-like features 19 . Thus, excessive systemic kynurenine pathway activity might contribute to post-inflammatory immunodeficiency and increase the risk of infections. Recently, Lögters et al showed that Trp shortage and increased Kyn plasma levels predict the development of sepsis in major trauma patients 20 .
Here we evaluated whether the quinolinic branch and/or the transamination side branch of the kynurenine pathway of Trp catabolism (leading to Quin or Kyna, respectively; Figure 1 ), become activated in severely ill patients who develop sepsis, and whether the increase of circulating Kyns results from impaired renal function.
MATERIAL AND METHODS

Patients
Prospective observational study
One hundred unselected consecutive patients who were admitted for different reasons to the surgical intensive care unit (ICU) of the university hospital of Greifswald, Germany, were enrolled. Inclusion criteria included informed consent for participation and age less than 18 years. The exclusion criteria were pregnancy, immunosuppression from cytotoxic therapy, high-dosage steroid therapy, participation in another trial, or moribund state. Patients or their FiGure 1: Major pathways of tryptophan catabolism. Trp is catabolised along the kynurenine pathway (bold arrows) providing NAD + . Alternative pathways are the conversion of Trp to serotonin (5-HT) and then to melatonin, or to tryptamine and then to kynurenamines (not shown). Indoleamines analysed in this study are shaded in gray. 1=Kyn formamidase, 2=kynureninase, 3=kynurenine3-hydroxylase, 4=kynureninase, 5=3-hydroxyanthranilic acid oxidase (3-HAO), 6=quinolinic acid phosphoribosyltransferase (QPRT), 7=kynurenine aminotransferases (KAT), 8=tryptophan hydroxylase. IDO=idoleamine 2,3-dioxgenase, TDO=tryptophan 2,3-dioxgenase. 21 as the presence of at least two of the following four signs: abnormal body temperature (>38°C or <36°C), tachycardia (greater than 90 beats/min), tachypnoea (more than 20 breaths/min) and abnormal white blood cell count (>12×10 9 /l, <4×10 9 /l). Sepsis is defined as SIRS due to a presumed or known infection. Severe sepsis was defined as sepsis with an associated acute organ failure. Septic shock, a subset of severe sepsis, was defined as a systolic arterial blood pressure of less than 90 mmHg or a reduction of greater than 40 mmHg from baseline values despite adequate fluid resuscitation, or as the need for administration of a vasopressor to maintain adequate arterial blood pressure. In the presence of a suspected or diagnosed clinical infection, all patients with shock who met SIRS criteria were considered to suffer from sepsis and therefore from septic shock. At baseline and daily thereafter, clinical and laboratory data, such as markers of disease severity and organ function, were obtained until discharge or death. Plasma samples for the quantification of indoleamines were collected from each patient at baseline and twice a week thereafter until discharge or death.
Post-hoc analysis of indoleamines in septic patients under selective extracorporeal immunoadsorption (IA) of LPS, IL6 and C5a
It was shown in a previous study 22 that simultaneously reducing circulating endotoxin, IL6 and C5a levels by selective immunoadsorption reverses monocyte deactivation and improves organ function in patients with severe sepsis and septic shock. We used the panel of plasma samples of these 11 IA-treated patients to answer the question of whether kynurenine pathway activity declines along with patients' recovery. Patients' characteristics were described in detail elsewhere 22 . Indoleamine plasma concentrations were analysed prior to (baseline), during (study day four) and after receiving immunotherapy (study day seven) in order to monitor tryptophan catabolism.
Healthy volunteers
Normal values of plasma indoleamine concentrations were obtained from the analysis of peripheral blood of 50 healthy blood donors (age 35.1±12.5 years; 54% males).
Analytical methods Plasma indoleamine concentrations
Samples of 100 µl plasma were analysed after addition of 50 µl sulfosalicylic acid (Sigma, Deisenhofen, Germany) (10 g in 90 ml methanol), 40 µl water and 10 µl internal standard solutions (d5-Trp, and d5-Kyna, Euriso-top, Paris, France). Samples were mixed, stored at 4°C for 30 minutes and centrifuged (20,000 g, 10 minutes). The supernatant was measured. A Wallac MS2 tandem mass spectrometer (Perkin Elmer, Rodgau, Germany) equipped with an electrospray ion source was used to record Trp, d5-Trp, Kyn, Quin 
Statistical analyses
Categorical data were expressed as percentages; for continuous data, mean with standard deviation or median with 25th and 75th percentiles were provided. Univariate analysis was performed with Fisher's exact test for categorical data and Kruskal-Wallis test (greater than two unpaired groups) or Mann-Whitney U-test (two unpaired groups) for continuous data. To evaluate differences in Kyns between controls and defined patient groups at baseline, variance analyses were applied. Dependent variables were log-transformed to better fulfill model assumptions. Analyses accounted for differences in age and gender between healthy controls and ICU patient groups. P values for post-hoc pairwise comparisons were corrected with Bonferroni's adjustment for multiple testing. P <0.05 was considered as statistically significant.
Non-parametric receiver operating characteristic analyses were applied to assess the predictive value of indoleamines regarding the development of sepsis during the ICU stay (positive event). To avoid a tendency towards cut-offs with lower sensitivity due to low frequency of the positive event, optimal cut-offs were chosen such that sensitivity and specificity are approximately equal. Positive and negative predictive values were calculated.
To analyse differences in means of indoleamine values in renal failure (RF) or septic shock, analyses of variance were performed, also taking the interaction of the two factors into account. For variance analyses, samples were chosen randomly, including one value per patient to avoid dependencies within patients. Randomisation resulted in 66 cases without septic shock or RF, 11 cases with RF (B), 12 cases with septic shock (C), and 11 cases with both RF and septic shock (D). Dependent variables were log-transformed because of large skewness within groups. Mean values of indoleamines were determined as predicted by the model.
To evaluate changes in indoleamine values during IA-treatment, repeated measures analyses of variance with post-hoc tests (paired t-tests and Wilcoxon signed rank tests as appropriate) were applied. Multiple testing P values were corrected according to Bonferroni's adjustment. Statistical analyses were carried out with SPSS (Version 11.5, Chicago, IL, USA) and R 2.7.0 (free shareware).
RESULTS
To analyse circulating indoleamine levels in critically ill patients, we monitored the kinetics of plasma concentrations of Trp, Kyn, Quin, Kyna and 5-HT of 100 patients during their stay in the ICU. Patients' demographics and baseline characteristics are shown in Table 1 . Among the 100 patients enrolled in the study, 50 did not develop sepsis during their stay in the ICU (A, non-septic). Eighteen patients did not have sepsis at baseline but developed it later within three days (25th to 75th, 2 to 7) (B, pre-septic). Thirty-two patients already fulfilled the criteria of severe sepsis and septic shock at baseline (C, septic). Compared with non-septic and pre-septic patients, patients with septic shock presented significantly increased SIRS and sequential organ failure assessment scores and a decreased monocytic HLA-DR expression at baseline, a higher percentage of acute renal failure, and significantly higher ICU mortality (P <0.05).
Activation of the kynurenine pathway in critically ill patients
The plasma Kyn/Trp ratio is considered to be a specific marker for IDO activity 20, 23 . At baseline, non-septic patients showed a significant increase of the plasma Kyn/Trp ratio when compared with a group of healthy volunteers (P <0.001; Figure  2A ). However, this resulted merely from a Trp shortage ( Figure 2C ) rather than from rising Kyn concentrations at that point in time ( Figure 2D ). Nevertheless, an activation of the kynurenine pathway in the critically ill was evident, because patients revealed increased levels of Quin ( Figure 2E ). This is underlined by an increased Quin/ Trp ratio ( Figure 2B ). Consistently, Trp depletion in the critically ill accompanied reduced serotonin plasma levels ( Figure 2G ).
Quinolinic branch activity of Trp catabolism predicts sepsis
Although non-septic critically ill patients showed signs of activation of the kynurenine pathway, the levels of Kyn, Quin, Kyna and the Quin/Trp ratio indicated a significant difference (P <0.001) between those patients and septic patients at baseline (Figure 2A and 2B ), suggesting either a further increase of Trp catabolism or damming of Kyns due to reduced renal clearance in patients with septic shock. Surprisingly, there was no significant difference between septic and pre-septic patients for any variable tested, whereas the quantification of Trp, Kyn, Quin and Kyna at baseline allowed the discrimination of patients who will or will not develop sepsis later on ( Figure 2 ). Therefore, we evaluated the ability of indoleamines to discriminate between non-septic and pre-septic patients at baseline applying receiver operating characteristic analyses ( Table 2 ). The Quin/Trp ratio was of the highest discriminatory power (AUC 0.835, 95% CI 0.719 to 0.952) followed by Quin (AUC 0.832, 95% CI 0.710 to 0.954), whereas Kyna, the product of the side branch of the kynurenine pathway (Figure 1) , was of less predictive value. For a Quin/Trp ratio ≥18.2, 73.3% of pre-septic patients and 86.0% of non-septic patients were classified correctly. Positive and negative predictive values were comparatively high. The fact that the concentrations of C-reactive protein and procalcitonin in the pre-septic group did not significantly differ from that of non-septic patients ( Table 2) underscores their pre-septic state.
Both renal failure and sepsis independently augment Kyn values
Indoleamines are rapidly cleared by renal filtration. It has been consistently shown that renal insufficiency leads to an accumulation of various Kyns 24 . Therefore, we asked whether RF exclusively contributed to the accumulation of Kyns during shock patients compared with those without RF and septic shock (0.8 µM and 0.3 µM vs 0.2 µM, respectively, P <0.05), and further increased to 2.4 µM on average in patients exhibiting both conditions. In contrast, Quin values which were lowest in patients without RF and septic shock (4 µM) increased independently in the presence of RF and septic shock (10.8 µM and 6.2 µM, respectively, P <0.05), but the presence of both RF and severe sepsis (interaction term) did not further augment Quin values in any relevant manner (P >0.05).
Plasma indoleamines as markers for disease severity in septic patients
In order to obtain an initial indication of whether the rise of plasma Kyns correlates with the severity of sepsis, we quantified indoleamines in the plasma of 11 patients enrolled in a recent study treating severe sepsis by a novel selective extracorporeal immunoadsorption approach to remove LPS, IL6 and C5a from the circulation. This intervention therapy led to recovery of monocytic HLA-DR expression and a significant decline in disease severity, as described in detail recently 22 . This selected table 3 Comparison of adjusted means (with 95% confidence interval [CI]) for plasma indoleamines in patients without septic shock or renal failure (A), with either renal failure (B) or septic shock (C), or both (D). For each patient one blood sample throughout their whole ICU stay was randomly chosen. Measured indoleamines were evaluated in ANOVA, analysing the impact of the presence of RF, presence of septic shock and the corresponding interaction term as factors. Significant P values for factors and the interaction are indicated in the corresponding columns. Model predicted means (with 95% CI) are provided in the (Figure 3 ). In particular, circulating Trp and 5-HT levels recovered along with the recovery of patients. Thus, kynurenine pathway activity seems to be a marker for the severity of illness.
DISCUSSION
Almost 120 years ago, Ehrlich 25 established that febrile infectious illnesses caused increased urinary excretion of aromatic amines which were identified several decades later as Trp catabolites of the kynurenine pathway 26 . This knowledge was virtually forgotten. Here, we show that Kyns, such as Kyn, Quin or Kyna, accumulate in the circulation when sepsis is developing. This raises the question of whether augmented Trp degradation is specific for infections. Our results show that this is not the case. Augmented Trp catabolism is a consistent finding in the heterogeneous population of severely ill patients. This may be explained by the fact that not only pathogen-associated molecular patterns but also endogenous alarmins, such as high mobility group box proteins, heat shock proteins or nucleosomes, contain hydrophobic motifs and are recognised by toll-like receptors [27] [28] [29] Given that basal levels of Trp in the blood are mainly controlled by TDO, which does not respond to pro-inflammatory mediators, one can speculate that during severe illness, TDO activity is up-regulated by stress-induced glucocorticoids 30 , leading to increased amino acid uptake by the liver and thereby lowering circulating Trp. This might be accompanied by the induction of IDO at sites of tissue injury in order to adapt to increased NAD + demand. The amount of NAD + in a cell indicates how much energy is available, either from glycolytic reactions to generate ATP and NADH or from oxidative phosphorylation using NADH via the electron transport chain. Plasma levels of indoleamines in non-septic critically ill patients illustrated such a proposed adaptation process. However, long-lasting severe depletion of Trp to 40% of normal values as shown in septic patients could have undesirable effects, such as successive NAD + depletion leading to tissue pathology. The cellular environment may become functionally hypoxic even in the presence of oxygen, and cellular hibernation in sepsis-associated organ dysfunction may at least in part reflect an underlying Trp shortage. Paradoxically, NAD + precursor molecules such Kyn or Quin accumulate in the circulation of septic patients, suggesting either an impaired cellular re-uptake, which has been identified by Romani et al 18 , or inactive intracellular downstream enzymes. As a result, these immunoactive Kyns may compromise immune functions.
In agreement with Lögters et al 20 , we found that when sepsis occurs, the concentration of circulating Kyn significantly exceeds that induced by stress, trauma or hypoxia in the non-septic critically ill. They measured Trp and Kyn and used the Kyn/Trp ratio to predict sepsis in 60 major trauma patients. In our study of 100 ICU patients admitted for different reasons, we analysed a broad spectrum of Kyns and identified the Quin/Trp ratio as having the best predictive value (AUC 0.835), superior to the Kyn/ Trp ratio (AUC 0.788). In addition, we showed that an accumulation of Kyns in the circulation does not necessarily depend on renal failure. Thus, an inability of septic patients to use Quin for NAD + synthesis has to be taken into account.
The potential importance of monitoring indoleamines is illustrated by the results from patients with severe sepsis and septic shock who underwent extracorporeal immunoadsorption, showing that removal of LPS, IL6, and C5a both beneficially influenced the overall progress of the study patients 22 and restored Trp and 5-HT concentrations within five days of treatment. Taken together, our results showed that excessive Trp degradation could be a risk factor for critically ill patients who, in principle, fulfill all the requirements for compromised immune and organ functions.
